Table 1.
Demographic characteristics at admission in patients infected with SARS-CoV-2 before the NAC treatment.
| Variables | Median and (Min–Max) |
|---|---|
| Age | 55 (27–84) |
| BMI | 28 (23–38) |
| Comorbidities | N (%) |
| Diabetes Mellitus | 8 (47) |
| Hypertension | 8 (47) |
| Dyslipidemia | 7 (41) |
| Normal Weight | 6 (35) |
| Overweight | 7 (41) |
| Obesity | 3 (24) |
| Signs | Median (Min–Max) |
| PaO2 | 70 (59–179) |
| PCO2 | 31.7 (12–39) |
| PaO2/FIO2 (mmHg) | 131.5 (45–282) |
| SPO2/FIO2 (mmHg) | 119 (61–290) |
| HR lpm | 74 (20–116) |
| MAP (mmHg) | 78 (71–102) |
| Temperature °C | 36 (36.5–37.2) |
| Glucose | 141 (100–359) |
| Creatinine in serum mg/dL | 0.85 (0.50–1.30) |
| BUN | 17 (5.6–36.6) |
| TC mg/dL | 133 (89–210) |
| TG mg/dL | 186.5 (80–726) |
| HDL-Cholesterol mg/dL | 26 (14–40) |
| LDL mg/dL | 62 (40–1109) |
| Leukocytes 10^3/µL | 8.8 (3.5–14.9) |
| Lymphocytes 10^3/µL | 8.3 (0.14–1.54) |
| Platelets 10^3/µL | 253 (164–408) |
| Ferritin ng/mL | 435.4 (146–2592) |
| D-dimer ng/dL | 605 (200–2100) |
| IL-6 pg/mL | 16.2 (7.8–324) |
| N/L | 8.4 (3–67) |
| C reactive protein mg/dL | 143.15 (44.7–221) |
| Procalcitonin ng/dL | 0.23 (0.08–11.4) |
| SOFA | 0 (0–3) |
| APACHE | 5.5 (4–8) |
| SAPS | 27 (18–32) |
| Patients in moderate condition | 8 (47%) |
| Patients with severe condition | 9 (53%) |
| Days With Mechanic ventilation | 13 (5–28) |
| Days in ICU | 17 (3–30) |
Abbreviations: BMI = body mass index, HR = heart rate, MAP = mean arterial pressure, HDL = high-density lipoproteins, LDL = low-density lipoproteins, IL = interleukin, N/L = neutrophils and/or lymphocytes. FiO2 = fraction of inspired oxygen, PAO2 = oxygen at arterial pressure, PCO2 = carbon dioxide at partial pressure, SpO2 = arterial oxygen saturation, TG = triglycerides. SOFA = Organ Failure Sequential Assessment, APACHE = Acute Physiology and Chronic Health Assessment II, SAPS = Simplified Acute Physiology II Score.